Invesco
ELDN icon

Invesco’s Eledon Pharmaceuticals ELDN Stock Holding History

Invesco’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
59,297
+28,329
+91% +$103K ﹤0.01% 3532
2026
Q1 		$95.4K Sell
30,968
-701
-2% -$1.65K ﹤0.01% 3631
2025
Q4 		$47.8K Sell
31,669
-222
-0.7% -$528 ﹤0.01% 3710
2025
Q3 		$82.6K Buy
31,891
+2,151
+7% +$6.29K ﹤0.01% 3707
2025
Q2 		$80.6K Buy
+29,740
New +$89.2K ﹤0.01% 3676
2015
Q3 		– Sell
-2
Closed -$5K – 3846
2015
Q2 		$5K Buy
+2
New +$3.87K ﹤0.01% 4195

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Invesco's ELDN Position: Q2 2026 in Review

Invesco increased its Eledon Pharmaceuticals (ELDN) stake by 91% in Q2 2026, buying an estimated $103K and bringing the position to 59,297 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #3532.

Invesco first reported a position in ELDN in Q2 2015 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Invesco held 59,297 shares of Eledon Pharmaceuticals worth $234K as of Q2 2026.
  • Invesco bought 28,329 Eledon Pharmaceuticals shares in Q2 2026, an estimated $103K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3532 holding.
  • Invesco first reported a position in Eledon Pharmaceuticals in Q2 2015 and has held it in 6 quarters since.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.